High dosage chlorpromazine alone and in combination with an antiparkinsonian agent (procyclidine) in the treatment of hospitalized depressions.
D000433:1-Propanol / Q000627:therapeutic use*; D000293:Adolescent; D000328:Adult; D000368:Aged; D000374:Aggression; D001007:Anxiety / Q000188:drug therapy; D001247:Asthenia / Q000188:drug therapy; D002746:Chlorpromazine / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003863:Depression / Q000188:drug therapy*; D004357:Drug Synergism; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010276:Parasympatholytics / Q000627:therapeutic use*; D010555:Personality Inventory; D010919:Placebos; D011352:Procyclidine / Q000009:adverse effects / Q000627:therapeutic use; D011759:Pyrrolidines / Q000627:therapeutic use*; D012893:Sleep Wake Disorders / Q000188:drug therapy; D013223:Statistics as Topic
D010276:Parasympatholytics; D010919:Placebos; D011759:Pyrrolidines; D000433:1-Propanol; D011352:Procyclidine; D002746:Chlorpromazine